MedPath logo

DUSPATALIN RETARD CAPSULE 200 mg

Pharmacy Only
Drug type: Therapeutic
ATC code: A03AA04
Dosage form: CAPSULE
Route of administration: ORAL
Active ingredient: MEBEVERINE HCl; MEBEVERINE HCl

Indications

Symptomatic treatment of abdominal pain and cramps, bowel disturbances and intestinal discomfort related to irritable bowel syndrome.

Treatment of gastro-intestinal spasm secondary to organ diseases.

Contraindications

Do not take this medicine if you are allergic (Hypersensitivity) to the active substance or to any of the excipients.

Dosage and administration

Adults

Take one capsule twice daily, one in the morning and one in the evening.

The capsules should be swallowed with a sufficient amount of water (at least 100 ml of water). They should not be chewed because the coating is intended to ensure a prolonged release mechanism.

Treatment Duration

Symptom relief occurs after a minimum of 2 to 4 weeks of treatment and greater effects can be observed after a prolonged therapy of 6 to 8 weeks.

Always take Duspatalin retard exactly as your doctor has prescribed. If you have any questions, check with your doctor or pharmacist.

In case of one or more dose(s) is (are) missed, you should continue with the next dose as prescribed; the missed dose(s) is (are) not to be taken in addition to the regular dose.

Paediatric Population

Duspatalin retard 200 mg capsules are not recommended for use in children and adolescents below 18, due to insufficient data on safety and efficacy.

Special Population

No posology studies in elderly, renal and/or hepatic impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatic impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.

Registrant
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Approval Date
1994-03-10
Approval Number
SIN07666P
Manufacturer
ABBOTT BIOLOGICALS B.V. Mylan Laboratories SAS
Licence Holder
ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED